Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 169

Similar articles for PubMed (Select 22461039)

1.

Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection.

Vos R, Vanaudenaerde BM, Verleden SE, Ruttens D, Vaneylen A, Van Raemdonck DE, Dupont LJ, Verleden GM.

Transplantation. 2012 Jul 27;94(2):101-9. doi: 10.1097/TP.0b013e31824db9da. Review.

PMID:
22461039
2.

Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection.

Federica M, Nadia S, Monica M, Alessandro C, Tiberio O, Francesco B, Mario V, Maria FA.

Clin Transplant. 2011 Jul-Aug;25(4):E381-9. doi: 10.1111/j.1399-0012.2011.01435.x. Epub 2011 Mar 21.

PMID:
21418327
3.
4.

Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.

Gottlieb J, Szangolies J, Koehnlein T, Golpon H, Simon A, Welte T.

Transplantation. 2008 Jan 15;85(1):36-41. doi: 10.1097/01.tp.0000295981.84633.bc.

PMID:
18192909
5.

Effect of maintenance azithromycin on established bronchiolitis obliterans syndrome in lung transplant patients.

Porhownik NR, Batobara W, Kepron W, Unruh HW, Bshouty Z.

Can Respir J. 2008 May-Jun;15(4):199-202.

6.

Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?

Verleden GM, Dupont LJ, Van Raemdonck DE.

Eur Respir J. 2005 Feb;25(2):221-4. Review.

7.

A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy.

Vanaudenaerde BM, Meyts I, Vos R, Geudens N, De Wever W, Verbeken EK, Van Raemdonck DE, Dupont LJ, Verleden GM.

Eur Respir J. 2008 Oct;32(4):832-43. doi: 10.1183/09031936.00134307. Review.

8.

Bile acids aspiration reduces survival in lung transplant recipients with BOS despite azithromycin.

Mertens V, Blondeau K, Van Oudenhove L, Vanaudenaerde B, Vos R, Farre R, Pauwels A, Verleden G, Van Raemdonck D, Sifrim D, Dupont LJ.

Am J Transplant. 2011 Feb;11(2):329-35. doi: 10.1111/j.1600-6143.2010.03380.x.

9.

Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation.

Verleden GM, Dupont LJ.

Transplantation. 2004 May 15;77(9):1465-7.

PMID:
15167610
10.

Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?

Verleden SE, Ruttens D, Vandermeulen E, Vaneylen A, Dupont LJ, Van Raemdonck DE, Verleden GM, Vanaudenaerde BM, Vos R.

Transplantation. 2013 May 15;95(9):1167-72. doi: 10.1097/TP.0b013e318286e076.

PMID:
23425818
11.

Chronic lung allograft dysfunction after lung transplantation: the moving target.

Sato M.

Gen Thorac Cardiovasc Surg. 2013 Feb;61(2):67-78. doi: 10.1007/s11748-012-0167-3. Epub 2012 Nov 10. Review.

PMID:
23138970
12.

A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation.

Vos R, Vanaudenaerde BM, Verleden SE, De Vleeschauwer SI, Willems-Widyastuti A, Van Raemdonck DE, Schoonis A, Nawrot TS, Dupont LJ, Verleden GM.

Eur Respir J. 2011 Jan;37(1):164-72. doi: 10.1183/09031936.00068310. Epub 2010 Jun 18.

13.

Obliterative bronchiolitis following lung transplantation: from old to new concepts?

Verleden GM, Vos R, De Vleeschauwer SI, Willems-Widyastuti A, Verleden SE, Dupont LJ, Van Raemdonck DE, Vanaudenaerde BM.

Transpl Int. 2009 Aug;22(8):771-9. doi: 10.1111/j.1432-2277.2009.00872.x. Epub 2009 Mar 26. Review.

PMID:
19490538
14.

The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation.

Morrell MR, Despotis GJ, Lublin DM, Patterson GA, Trulock EP, Hachem RR.

J Heart Lung Transplant. 2010 Apr;29(4):424-31. doi: 10.1016/j.healun.2009.08.029. Epub 2009 Oct 22.

PMID:
19853479
15.

Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome.

Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE.

Am J Respir Crit Care Med. 2006 Sep 1;174(5):566-70. Epub 2006 Jun 1.

PMID:
16741151
16.

Azithromycin improves lung function in patients with post-lung transplant bronchiolitis obliterans syndrome: a meta-analysis.

Kingah PL, Muma G, Soubani A.

Clin Transplant. 2014 Aug;28(8):906-10. doi: 10.1111/ctr.12401. Epub 2014 Jul 9.

PMID:
24931185
17.

Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients.

Shitrit D, Bendayan D, Gidon S, Saute M, Bakal I, Kramer MR.

J Heart Lung Transplant. 2005 Sep;24(9):1440-3.

PMID:
16143268
18.

Development of bronchiolitis obliterans syndrome despite blood chimerism in human lung transplant recipients.

Calhoun R, SivaSai KS, Sundaresan S, Trulock EP, Lynch JP, Patterson GA, Cooper JD, Mohanakumar T.

Transpl Int. 1999;12(6):439-46.

PMID:
10654356
19.

Efficacy of total lymphoid irradiation in azithromycin nonresponsive chronic allograft rejection after lung transplantation.

Verleden GM, Lievens Y, Dupont LJ, Van Raemdonck DE, De Vleeschauwer SI, Vos R, Vanaudenaerde BM.

Transplant Proc. 2009 Jun;41(5):1816-20. doi: 10.1016/j.transproceed.2009.03.070.

PMID:
19545735
20.

Extracorporeal photopheresis for the treatment of lung allograft rejection.

Villanueva J, Bhorade SM, Robinson JA, Husain AN, Garrity ER Jr.

Ann Transplant. 2000;5(3):44-7.

PMID:
11233043
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk